Showing results (11-20 of 272) with videos related to
Sort By:
Pageof 28
The Journal of Antimicrobial Chemotherapy|November 22, 2018
Intravenous catheter-related adverse events exceed drug-related adverse events in outpatient parenteral antimicrobial therapyJonathan Underwood, Michael Marks, Steve Collins, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 28, 2015
Thromboelastography in the Management of Coagulopathy Associated With Ebola Virus DiseaseAndrew J Wilson, Daniel S Martin, Victoria Maddox, et al.BMJ Case Reports|August 2, 2013
Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome secondary to antituberculosis drugs and associated with human herpes virus-7 (HHV-7)Nehal Draz, Sumona Datta, Daniel P Webster, et al.Plos Pathogens|April 21, 2026
Context-specific roles for IL-17 in tuberculosisMahlatse Maseeme, Liku B Tezera, Mahdad Noursadeghi, et al.Jac-Antimicrobial Resistance|December 20, 2024
Antimicrobial resistance-attributable mortality: a patient-level analysisIoannis Baltas, Timothy Miles Rawson, Hamish Houston, et al.Journal of Immunological Methods|March 22, 2005
The use of targeted microbeads for quantitative analysis of the phagocytic properties of human monocyte-derived dendritic cellsMatthew E Handley, Gabriele Pollara, Benjamin M Chain, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2008
Glycoprotein-dependent and TLR2-independent innate immune recognition of herpes simplex virus-1 by dendritic cellsAdi Reske, Gabriele Pollara, Claude Krummenacher, et al.BMC Medicine|March 24, 2016
Diagnostic 'omics' for active tuberculosisCarolin T Haas, Jennifer K Roe, Gabriele Pollara, et al.Reviews in Medical Virology|February 14, 2007
Understanding HSV-1 entry glycoproteinsAdi Reske, Gabriele Pollara, Claude Krummenacher, et al.Expert Opinion on Drug Safety|March 30, 2005
Drug-induced aseptic meningitisSusan Hopkins, Stephen JollesPageof 28